Researcher At Heart: Toichi Takenaka's Journey From 'Empty Lab' To CEO
Ex-Astellas Chief Sees R&D Funding As Challenge
Executive Summary
Dr Toichi Takenaka, the first winner of the Lifetime Achievement Award in the inaugural Pharma Intelligence Awards Japan earlier this year, talks to Scrip about his journey from researcher to CEO and today as a mentor for Japanese bioventures. Starting his career in an “empty lab” in the 1960s motivated him to pursue a string of collaborations with universities in Japan and on to the discovery of four successful drugs.
You may also be interested in...
Japan’s Biopharma Excellence Celebrated At Pharma Intelligence Awards
Excellence, innovation, deal-making and individual achievement across the Japanese biopharma sector were celebrated at the inaugural Pharma Intelligence Japan Awards 2022 in Tokyo on 1 September.
All change at the top at Astellas
Astellas is reshuffling its top management, naming current chief financial officer and chief strategy officer Yoshihiko Hatanaka as president and CEO, subject to formal board and shareholder approval in June.
Japan Price Revision: Mixture of Cuts And Increases Amid Supply Crisis
Japan’s annual drug reimbursement price revision for 2023 will cut approximately $2.3bn from national healthcare costs, and while several temporary price increases have been granted to cope with an ongoing supply crisis for some products, a system of one-off revisions for big sellers remains.